Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-021222
Filing Date
2024-02-13
Accepted
2024-02-13 17:08:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv01216-intracellulartherapi.htm SC 13G/A 11494
  Complete submission text file 0001104659-24-021222.txt   13139
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87380 | Film No.: 24628790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)